About
Acceptance rate
35%
Time to first decision
20 days*
Time from acceptance to publication
19 days
Citescore
3.2
2020 total content views
187,738
Aims and scope
Frontline Gastroenterology publishes articles that accelerate adoption of innovative and best practice in the fields of gastroenterology, hepatology and clinical nutrition. Frontline Gastroenterology is especially interested in articles on multidisciplinary research and care, focusing on both retrospective assessments of novel models of care as well as putative future directions of best practice. Specifically Frontline Gastroenterology publishes articles in the domains of clinical quality, patient experience, service provision and medical education.
Frontline Gastroenterology is an official publication of the British Society of Gastroenterology and is a companion journal to Gut and BMJ Open Gastroenterology. BSG members receive free access to FG as a benefit of membership. The journal is also affiliated with BAPEN and BSPGHAN; members receive a discounted subscription to the journal.
For information about Frontline Gastroenterology Editor-in-Chief Professor Mark Beattie and his editorial team, please refer to the Editorial Board page.
Plan S compliance
Frontline Gastroenterology is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and  Plan S compliance on our Author Hub.
Journal information
| Ownership | Frontline Gastroenterology is co-owned by the British Society of Gastroenterology and BMJ |
|---|---|
| Publication Model | Subscription; with hybrid open access option |
| Frequency | Quarterly (6 issues from 2020) |
| Launch date | 2010 |
| Digital Archives | Portico, LOCKSS |
| Indexed by | Web of Science Core Collection: Emerging Sources Citation Index; PubMed Central; Scopus; Embase (Excerpta Medica); CINAHL; Google Scholar |
| Peer Review Model | Single blind; the names of reviewers are hidden from the author |
| ISSN | 2041-4137 |
| ISSN (online) | 2041-4145 |
Articles published in Frontline Gastroenterology are held under an embargo for 12 months following publication in an issue. After this articles are made free to access and deposited in PubMed Central.
Journal Statistics (2020)
Acceptance rate: 35%
Speed
Time to first decision: 20 days (mean)
Time from acceptance to publication: 19 days (mean)
Impact
Citescore: 3.2
Citescore rank: 76/136
Scimago Journal Rank (SJR): 0.919
Reach
2020 total content views: 187,740
2020 total Altmetric mentions: 3,008
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.
Contact information
For all contact information please refer to the Contact Us page.
For authors
Please refer to the Instructions for Authors.
Subscriptions
To advertise
Rights and permissions
Affiliations
Members of the British Society of Gastroenterology receive Frontline Gastroenterology as a benefit of membership; members should login to the British Society of Gastroenterology website to access the journal.
Members of BSPGHAN receive a discounted subscription rate to Frontline Gastroenterology as a benefit of membership; members should login to the BSPGHAN website for more information.
BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve reliability and value of medical research literature by promoting transparent and accurate reporting of research studies. BMJ is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.